Abstract:Objective To investigate the value of two-dimensional ultrasound combined with superb microvascular imaging (SMI) in the preoperative staging of cervical cancer. Methods Seventy-six patients diagnosed with cervical cancer by pathological biopsy in People's Hospital of Guangxi Zhuang Autonomous Region between November 2018 and December 2019 were selected. All patients underwent two-dimensional transvaginal ultrasound combined with SMI and MRI before operation. Taking postoperative pathological results as the gold standard, the accuracy and sensitivity of the two examination methods for the staging of cervical cancer were analyzed. Results Among 76 cases of cervical cancer, 3 cases were stage IA, 57 cases were stage IB, and 16 cases were stage Ⅱ. The overall accuracy rate in the cervical cancer staging of two-dimensional ultrasound combined with SMI was 77.6% (59/76) and that of MRI was 73.7% (56/76), between which the difference was not statistically significant (P > 0.05). The accuracy rates of two-dimensional ultrasound combined with SMI in the diagnosis of IB1 and IB2 were both higher than those of MRI (P < 0.05). When the tumor was less than 2 cm or in between 2-4 cm, the diagnostic sensitivity of two-dimensional ultrasound combined with SMI was 87.5% and 93.8% respectively, which was higher than that of MRI (84.0% and 87.5%). Conclusions Two-dimensional ultrasound combined with SMI has the advantages of low cost, allowing repeated operation as well as being non-invasive in the preoperative staging of early cervical cancer, which can provide an important basis for the formulation of treatment regimens for cervical cancer patients.